MoneyWorks4Me

Hester Biosciences - Quaterly Results

31 Jan 2022 Evaluate
With no major difference for the quarter endedDecember 2021 , the total revenue stood at Rs. 540.01  millions.The Net proft of the company remain more or less same to Rs. 105.58  millions from Rs. 132.91 millions ,decline by -20.56%.A decline of 164.53 millions was observed in the OP in the quarter ended December 2021 from 212.19 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 540.01 528.18 2.24 1691.00 1453.19 16.36 2084.77 1694.25 23.05
Other Income 12.22 6.35 92.44 35.76 15.28 134.03 16.48 29.27 -43.70
PBIDT 164.53 212.19 -22.46 540.91 529.06 2.24 736.41 556.48 32.33
Interest 3.65 9.38 -61.09 10.85 34.75 -68.78 39.47 50.34 -21.59
PBDT 160.88 202.81 -20.67 530.06 494.31 7.23 644.16 506.14 27.27
Depreciation 23.34 24.36 -4.19 69.54 71.88 -3.26 96.33 93.85 2.64
PBT 137.54 178.45 -22.93 460.52 422.43 9.02 547.83 412.29 32.87
TAX 31.96 45.54 -29.82 114.83 112.01 2.52 148.82 100.05 48.75
Deferred Tax -3.37 -1.03 227.18 -8.06 -1.86 333.33 -14.83 -18.00 -17.61
PAT 105.58 132.91 -20.56 345.69 310.42 11.36 399.01 312.24 27.79
Equity 85.07 85.07 0.00 85.07 85.07 0.00 85.07 85.07 0.00
PBIDTM(%) 30.47 40.17 -24.16 31.99 36.41 -12.14 35.32 32.85 7.54
Peers
Company Name CMP
Sun Pharma. Inds. 1748.90
Dr. Reddys Labs. 1214.10
Cipla 1312.85
Lupin 1954.80
Zydus Lifesciences 1124.00
View more..